First graph, end of first sentence of release dated June 1, 2009, time
should be 1:10 p.m. (CDT) (sted 1:10 p.m. (EDT)).
The corrected release reads:
DEXCOM TO PRESENT AT THE 2009 WILLIAM BLAIR GROWTH STOCK CONFERENCE
DexCom, Inc. (NASDAQ:DXCM) today announced that Terrance Gregg,
President and Chief Executive Officer, will present an update on DexCom
at the 2009 William Blair Growth Stock Conference in Chicago on Tuesday,
June 9th, 2009 at 1:10 p.m. (CDT). The presentation, which will occur
live at the Four Seasons Hotel in Chicago, will be concurrently webcast.
The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com
under the investor webcast section and will be archived for future
reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and
marketing continuous glucose monitoring systems for ambulatory use by
patients and by healthcare providers in the hospital.
Cautionary Statement Regarding Forward Looking Statements
DexCom is a medical device company with a limited operating history.
Successful commercialization of the company’s products is subject to
numerous risks and uncertainties, including a lack of acceptance in the
marketplace by physicians and patients, the inability to manufacture
products in commercial quantities at an acceptable cost, possible delays
in the company’s development programs, the inability of patients to
receive reimbursement from third-party payors and inadequate financial
and other resources. Certain of these risks and uncertainties, in
addition to other risks, are more fully described in the company’s
annual report on Form 10-Q for the period ending March 31, 2009, as
filed with the Securities and Exchange Commission on May 6, 2009.
DexCom, Inc.
Steven R. Pacelli, Chief Administrative Officer
858-200-0200
